Myc is aberrantly activated in a number of human cancers [84,85,86,87,88,89,90] and acts by heterodimerization with Max via their helix-loop-helix leucine zipper domains, a process that leads to the transcription of Myc target genes. The gene discussed is MYC; the disease is cancer.